A Study of Pamiparib Combined With Abiraterone Acetate in Neoadjuvant Treatment of Prostate Cancer
Clinical trial NCT05376722 · UNKNOWN
Trial details
- NCT number
- NCT05376722
- Sponsor
- Hongqian Guo
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-22
- Primary completion
- 2023-09-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.